PAVE (Parallactic Visual-Field Enhancement) System for Treatment of Chronic Visual Field Loss Due to Stroke, Traumatic Brain Injury, or Brain Surgery

Clinical trial NCT07185971 · RECRUITING

Trial details

NCT number: NCT07185971
Sponsor: NeuroAEye LLC
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Homonymous Hemianopsia Homonymous Quadrantanopia

Start date: 2026-03-16
Primary completion: 2026-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.